lilly's glp 1 Lilly is now pharma's top revenue company. It just got FDA approval for an oral GLP-1, but Wall Street isn't celebrating Lilly's Double-Beat Widens the GLP-1
Description
All options are prescribed by licensed US clinicians following a full individual symptom and health history assessment
In Eli Lillys complaints against Mochi Health and Fella Health, however, Eli Lilly alleges that this boundary was crossed, and both Mochi Health and Fella Health exerted undue influence and control over medical decision-making
Most users are evaluated and approved within a few business days, with medications arriving shortly after approval
3 Lincoff AM et al
